pyridostigmine bromide has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Govindarajan, R; Singh, S | 1 |
| da Silva, CA; Fazan, R; Giusti, H; Glass, ML; Sabino, JP; Salgado, HC | 1 |
2 other study(ies) available for pyridostigmine bromide and Hypoxia
| Article | Year |
|---|---|
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
Topics: Adult; Betacoronavirus; Cholinesterase Inhibitors; Coronavirus Infections; COVID-19; Disease Progression; Female; Glucocorticoids; Humans; Hypercapnia; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Myasthenia Gravis; Mycophenolic Acid; Pandemics; Plasma Exchange; Pneumonia, Viral; Prednisone; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Thymectomy; Tomography, X-Ray Computed | 2020 |
Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.
Topics: Animals; Cholinesterase Inhibitors; Disease Models, Animal; Heart Failure; Heart Rate; Hypercapnia; Hypoxia; Male; Parasympathetic Nervous System; Pulmonary Ventilation; Pyridostigmine Bromide; Rats; Rats, Wistar | 2013 |